QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kalivas, P. W. Articles by Duffy, P. Search for Related Content PubMed PubMed Citation Articles by Kalivas, P. W. Articles by Duffy, P.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 10, 2940-2949, Copyright © 1990 by Society for Neuroscience

ARTICLE

Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens

PW Kalivas and P Duffy
Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University, Pullman 99164-6520.

The injection of neurotensin or the enkephalin analog Tyr-D-Ala-Gly- MePhe-Gly(ol) (DAMGO) into the A10 region of rats produces a motor stimulant effect that is associated with an increase in the postmortem levels of dopamine metabolites in the nucleus accumbens. These behavioral and neurochemical effects are augmented following daily administration. In vivo dialysis in the nucleus accumbens of conscious rats was used to determine if the acute and augmented behavioral responses following neurotensin or DAMGO administration are associated with an increase in extracellular dopamine concentrations. The acute injection of DAMGO produced a dose-dependent (0.03-3.3 nmol) elevation in extracellular dopamine and its metabolites in the nucleus accumbens. Neurotensin also produced a dose-related (0.1-3.3 nmol) increase in dopamine and its metabolites. The elevation in extracellular dopamine produced by DAMGO, but not by neurotensin, was positively correlated with the increase in motor activity. Following daily treatment of either neurotensin (1.0 nmol X 4 d) or DAMGO (0.03 nmol X 4 d), a significant elevation in extracellular dopamine levels occurred in the nucleus accumbens compared to an acute injection. The time course of the change in extracellular dopamine after daily injections was similar to the time course of the behavioral stimulation for both compounds. These data demonstrate that enhanced dopamine release in the nucleus accumbens mediates the acute behavioral effect of DAMGO but does not entirely explain the motor effects of neurotensin. However, enhanced dopamine release may mediate the behavioral sensitization produced by daily injection of both peptides into the A10 region.

This article has been cited by other articles:

				M. M. Torregrossa and P. W. Kalivas Neurotensin in the Ventral Pallidum Increases Extracellular {gamma}-Aminobutyric Acid and Differentially Affects Cue- and Cocaine-Primed Reinstatement J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 556 - 566. [Abstract] [Full Text] [PDF]

				C. P. Ford, M. J. Beckstead, and J. T. Williams Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents J Neurophysiol, January 1, 2007; 97(1): 883 - 891. [Abstract] [Full Text] [PDF]

				F. St-Gelais, M. Legault, M.-J. Bourque, P.-P. Rompre, and L.-E. Trudeau Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons J. Neurosci., March 10, 2004; 24(10): 2566 - 2574. [Abstract] [Full Text] [PDF]

				J. L. Cornish, M. Nakamura, and P. W. Kalivas Dopamine-Independent Locomotion Following Blockade of N-Methyl-D-aspartate Receptors in the Ventral Tegmental Area J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 226 - 233. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help